On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Pharmacoidea Fejleszto Es Szolgaltato Kft's own share of each project, not the project's full budget.
- Horizon 2020€1.3M · 3 projects
- Horizon Europe€1.2M · 4 projects
- FP7 (2007 to 2013)€919k · 2 projects
Projects
9 EU-funded projects, newest first. Pharmacoidea Fejleszto Es Szolgaltato Kft led 1 of them as coordinator. Each links to the official record.
- SYNEADCoordinator
SYNDECAN-3 BASED BLOOD TEST FOR EARLY ALZHEIMER’S DIAGNOSIS
Horizon Europe · 2026–2028 · Project on CORDIS ↗
€485ktheir share - SECUREPartner
SYNTHETIC GENE CIRCUITS FOR CLOSED-LOOP THERAPY
Horizon Europe · 2026–2029 · Project on CORDIS ↗
€205ktheir share - COMMUTEPartner
COMORBIDITY MECHANISMS UTILIZED IN HEALTHCARE
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€340ktheir share - PREDICTOMPartner
PREDICTION OF ALZHEIMER’S DISEASE USING AN AI DRIVEN SCREENING PLATFORM
Horizon Europe · 2023–2027 · Project on CORDIS ↗
€200ktheir share - ARDATPartner
Accelerating Research & Development for Advanced Therapies
Horizon 2020 · 2020–2026 · Project on CORDIS ↗
€502ktheir share - NEUROPAPartner
Non-invasive dynamic neural control by laser-based technology
Horizon 2020 · 2020–2023 · Project on CORDIS ↗
€473ktheir share - IM2PACTPartner
Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics (IM2PACT) Into The Brain
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€300ktheir share - AETIONOMYPartner
Aetionomy – Organising Mechanistic Knowledge about Neurodegenerative Diseases for the Improvement of Drug Development and Therapy
FP7 (2007 to 2013) · 2014–2018 · Project on CORDIS ↗
€359ktheir share - COMPACTPartner
Collaboration on the Optimisation of Macromolecular Pharmaceutical Access to Cellular Targets
FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗
€560ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 5 shared projects
- Novo Nordisk A/SDenmark · 4 shared projects
- Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung eVGermany · 3 shared projects
- Kobenhavns UniversitetDenmark · 3 shared projects
- Cardiff UniversityUnited Kingdom · 3 shared projects
- Sanofi-Aventis Recherche & DeveloppementFrance · 3 shared projects
- Novartis Pharma AGSwitzerland · 3 shared projects
- Pfizer LimitedUnited Kingdom · 3 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 2 shared projects
- University College LondonUnited Kingdom · 2 shared projects
- Ludwig-Maximilians-Universitaet MuenchenGermany · 2 shared projects
- Universitat WienAustria · 2 shared projects
- The University of SheffieldUnited Kingdom · 2 shared projects
- Ruprecht-Karls-Universitaet HeidelbergGermany · 2 shared projects
- Stichting Amsterdam UmcNetherlands · 2 shared projects
- Universite du LuxembourgLuxembourg · 2 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- alzheimer
- artificial intelligence
- big data
- biomolecules
- coronaviruses
- dementia
- drug discovery
- drug safety
- gene therapy
- genomes
- immunology
- laboratory samples analysis
- laser physics
- nanotechnology
Pharmacoidea Fejleszto Es Szolgaltato Kft is listed on EUACC
See the startup profile for its product, team and what it is looking for.
Open the startup profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗
